Your browser doesn't support javascript.
loading
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma.
Guenther, Lillian M; Dharia, Neekesh V; Ross, Linda; Conway, Amy; Robichaud, Amanda L; Catlett, Jerrel L; Wechsler, Caroline S; Frank, Elizabeth S; Goodale, Amy; Church, Alanna J; Tseng, Yuen-Yi; Guha, Rajarshi; McKnight, Crystal G; Janeway, Katherine A; Boehm, Jesse S; Mora, Jaume; Davis, Mindy I; Alexe, Gabriela; Piccioni, Federica; Stegmaier, Kimberly.
Afiliación
  • Guenther LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Dharia NV; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Ross L; Broad Institute, Cambridge, Massachusetts.
  • Conway A; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Catlett JL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Wechsler CS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Frank ES; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Goodale A; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Church AJ; Broad Institute, Cambridge, Massachusetts.
  • Tseng YY; Broad Institute, Cambridge, Massachusetts.
  • Guha R; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts.
  • McKnight CG; Broad Institute, Cambridge, Massachusetts.
  • Janeway KA; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.
  • Boehm JS; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.
  • Mora J; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Davis MI; Broad Institute, Cambridge, Massachusetts.
  • Alexe G; Department of Pediatric Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Piccioni F; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.
  • Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
Clin Cancer Res ; 25(4): 1343-1357, 2019 02 15.
Article en En | MEDLINE | ID: mdl-30397176
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sarcoma de Ewing / Receptor IGF Tipo 1 / Quinasa 4 Dependiente de la Ciclina / Quinasa 6 Dependiente de la Ciclina Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sarcoma de Ewing / Receptor IGF Tipo 1 / Quinasa 4 Dependiente de la Ciclina / Quinasa 6 Dependiente de la Ciclina Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article